{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:29:58Z","timestamp":1792794598324,"version":"4.5.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Aurinia Pharmaceuticals Inc.","id":[{"id":"https:\/\/ror.org\/032akv382","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,20]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Calcineurin inhibitors (CNIs) affect kidney electrolyte handling and blood pressure (BP) through an effect on the distal tubule. The second-generation CNI voclosporin causes hypomagnesaemia and hypercalciuria less often than tacrolimus. This suggests different effects on the distal tubule, but this has not yet been investigated experimentally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Rats were treated with voclosporin, tacrolimus or vehicle for 28\u00a0days. Dosing was based on a pilot experiment to achieve clinically therapeutic concentrations. Drug effects were assessed by electrolyte handling at day 18 and 28, thiazide testing at day 20, telemetric BP recordings and analysis of messenger RNA (mRNA) and protein levels of distal tubular transporters at day 28.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with vehicle, tacrolimus but not voclosporin significantly increased the fractional excretions of calcium (&amp;gt;4-fold), magnesium and chloride (both 1.5-fold) and caused hypomagnesaemia. Tacrolimus but not voclosporin significantly reduced distal tubular transporters at the mRNA and\/or protein level, including the sodium\u2013chloride cotransporter, transient receptor melastatin 6, transient receptor potential vanilloid 5, cyclin M2, sodium\u2013calcium exchanger and calbindin-D28K. Tacrolimus but not voclosporin reduced the mRNA level and urinary excretion of epidermal growth factor. The saluretic response to hydrochlorothiazide at day 20 was similar in the voclosporin and vehicle groups, whereas it was lower in the tacrolimus group. The phosphorylated form of the sodium\u2013chloride cotransporter was significantly higher at day 28 in rats treated with voclosporin than in those treated with tacrolimus. Tacrolimus transiently increased BP, whereas voclosporin caused a gradual but persistent increase in BP that was further characterized by high renin, normal aldosterone and low endothelin-1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In contrast to tacrolimus, voclosporin does not cause hypercalciuria and hypomagnesaemia, but similarly causes hypertension. Our data reveal differences between the distal tubular effects of tacrolimus and voclosporin and provide a pathophysiological basis for the clinically observed differences between the two CNIs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfae119","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T21:51:37Z","timestamp":1716414697000},"page":"151-163","source":"Crossref","is-referenced-by-count":12,"title":["Calcineurin inhibitor effects on kidney electrolyte handling and blood pressure: tacrolimus versus voclosporin"],"prefix":"10.1093","volume":"40","author":[{"given":"Kuang-Yu","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam , Rotterdam ,","place":["The Netherlands"]},{"name":"Department of Internal Medicine, Division of Nephrology, Tri-Service General Hospital, National Defense Medical Center , Taipei ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn H","family":"van Heugten","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter H","family":"van Megen","sequence":"additional","affiliation":[{"name":"Department of Medical BioSciences, Radboud University Medical Center , Nijmegen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"van Veghel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Vascular Medicine, Pharmacology, and Metabolic Diseases, Erasmus MC, University Medical Center Rotterdam , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M","family":"Rehaume","sequence":"additional","affiliation":[{"name":"Aurinia Pharmaceuticals Inc. , Edmonton, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L","family":"Cross","sequence":"additional","affiliation":[{"name":"Aurinia Pharmaceuticals Inc. , Edmonton, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"Viel","sequence":"additional","affiliation":[{"name":"Aurinia Pharmaceuticals Inc. , Edmonton, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester","family":"van Willigenburg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Henrique Imenez","family":"Silva","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A H Jan","family":"Danser","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Vascular Medicine, Pharmacology, and Metabolic Diseases, Erasmus MC, University Medical Center Rotterdam , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2372-8486","authenticated-orcid":false,"given":"Jeroen H F","family":"de Baaij","sequence":"additional","affiliation":[{"name":"Department of Medical BioSciences, Radboud University Medical Center , Nijmegen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8738-3571","authenticated-orcid":false,"given":"Ewout J","family":"Hoorn","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"key":"2025010614204067500_bib1","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/TP.0000000000003350","article-title":"Thirty years of tacrolimus in clinical practice","volume":"105","author":"Ong","year":"2021","journal-title":"Transplantation"},{"key":"2025010614204067500_bib2","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1681\/ASN.V981416","article-title":"Inhibition of calbindin D28K expression by cyclosporin A in rat kidney: the possible pathogenesis of cyclosporin A-induced hypercalciuria","volume":"9","author":"Yang","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2025010614204067500_bib3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/01.ASN.0000113318.56023.B6","article-title":"Downregulation of Ca2+ and Mg2+ transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia","volume":"15","author":"Nijenhuis","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2025010614204067500_bib4","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/nm.2497","article-title":"The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension","volume":"17","author":"Hoorn","year":"2011","journal-title":"Nat Med"},{"key":"2025010614204067500_bib5","doi-asserted-by":"publisher","first-page":"F486","DOI":"10.1152\/ajprenal.00116.2011","article-title":"Expression of renal distal tubule transporters TRPM6 and NCC in a rat model of cyclosporine nephrotoxicity and effect of EGF treatment","volume":"301","author":"Ledeganck","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"2025010614204067500_bib6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1365-2362.2011.02517.x","article-title":"Cyclosporine metabolic side effects: association with the WNK4 system","volume":"41","author":"Melnikov","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"2025010614204067500_bib7","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1681\/ASN.2015040466","article-title":"Renal deletion of 12\u00a0kDa FK506-binding protein attenuates tacrolimus-induced hypertension","volume":"27","author":"Lazelle","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2025010614204067500_bib8","doi-asserted-by":"publisher","first-page":"e14316","DOI":"10.14814\/phy2.14316","article-title":"Tacrolimus-induced hypomagnesemia and hypercalciuria requires FKBP12 suggesting a role for calcineurin","volume":"8","author":"Gratreak","year":"2020","journal-title":"Physiol Rep"},{"key":"2025010614204067500_bib9","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/ndt\/gfg515","article-title":"Hyponatraemia and hyperkalaemia are more frequent in renal transplant recipients treated with tacrolimus than with cyclosporin. Further evidence for differences between cyclosporin and tacrolimus nephrotoxicities","volume":"19","author":"Higgins","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"2025010614204067500_bib10","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1097\/00007890-199306000-00023","article-title":"Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients","volume":"55","author":"Textor","year":"1993","journal-title":"Transplantation"},{"key":"2025010614204067500_bib11","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1161\/HYPERTENSIONAHA.122.19189","article-title":"Tacrolimus causes hypertension by increasing vascular contractility via RhoA (Ras homolog family member A)\/ROCK (Rho-associated protein kinase) pathway in mice","volume":"79","author":"Wang","year":"2022","journal-title":"Hypertension"},{"key":"2025010614204067500_bib12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/ndt\/gfad161","article-title":"Cyclosporin-induced hypertension is associated with the up-regulation of Na+-K+-2Cl\u2212 cotransporter (NKCC2)","volume":"39","author":"Capolongo","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2025010614204067500_bib13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1152\/physrev.00044.2018","article-title":"Regulation of the renal NaCl cotransporter and its role in potassium homeostasis","volume":"100","author":"Hoorn","year":"2020","journal-title":"Physiol Rev"},{"key":"2025010614204067500_bib14","doi-asserted-by":"publisher","first-page":"F499","DOI":"10.1152\/ajprenal.90489.2008","article-title":"The calcineurin inhibitor FK506 (tacrolimus) is associated with transient metabolic acidosis and altered expression of renal acid-base transport proteins","volume":"297","author":"Mohebbi","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"2025010614204067500_bib15","first-page":"83","article-title":"Pharmacokinetic disposition difference between cyclosporine and voclosporin drives their distinct efficacy and safety profiles in clinical studies","volume":"12","author":"Li","year":"2020","journal-title":"Clin Pharmacol"},{"key":"2025010614204067500_bib16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/17512433.2022.2092470","article-title":"Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis","volume":"15","author":"van Gelder","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2025010614204067500_bib17","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1111\/j.1600-6143.2011.03763.x","article-title":"The PROMISE study: a phase 2b multicenter study of voclosporin (ISA247) versus tacrolimus in de novo kidney transplantation","volume":"11","author":"Busque","year":"2011","journal-title":"Am J Transplant"},{"key":"2025010614204067500_bib18","doi-asserted-by":"publisher","first-page":"bqaa162","DOI":"10.1210\/endocr\/bqaa162","article-title":"Differential effects of voclosporin and tacrolimus on insulin secretion from human islets","volume":"161","author":"Kolic","year":"2020","journal-title":"Endocrinology"},{"key":"2025010614204067500_bib19","first-page":"176","article-title":"Serum magnesium, hepatocyte nuclear factor 1\u03b2 genotype and post-transplant diabetes mellitus: a prospective study","volume":"35","author":"van der Burgh","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2025010614204067500_bib20","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/S0140-6736(08)60593-0","article-title":"Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study","volume":"371","author":"Papp","year":"2008","journal-title":"Lancet"},{"key":"2025010614204067500_bib21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.kint.2018.08.025","article-title":"A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis","volume":"95","author":"Rovin","year":"2019","journal-title":"Kidney Int"},{"key":"2025010614204067500_bib22","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet"},{"key":"2025010614204067500_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/art.42657","article-title":"Safety and efficacy of long-term voclosporin treatment for lupus nephritis in the phase 3 AURORA 2 clinical trial","volume":"76","author":"Saxena","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2025010614204067500_bib24","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1681\/ASN.2016090948","article-title":"Constitutively active SPAK causes hyperkalemia by activating NCC and remodeling distal tubules","volume":"28","author":"Grimm","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2025010614204067500_bib25","doi-asserted-by":"publisher","first-page":"F62","DOI":"10.1152\/ajprenal.00668.2016","article-title":"Responses of distal nephron Na+ transporters to acute volume depletion and hyperkalemia","volume":"313","author":"Frindt","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"2025010614204067500_bib26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4155\/bio-2021-0247","article-title":"Validation of a dried blood spot method to measure tacrolimus concentrations in small volumes of mouse blood","volume":"14","author":"Willigenburg","year":"2022","journal-title":"Bioanalysis"},{"key":"2025010614204067500_bib27","doi-asserted-by":"publisher","first-page":"F518","DOI":"10.1152\/ajprenal.00656.2020","article-title":"A plasma creatinine- and urea-based equation to estimate glomerular filtration rate in rats","volume":"320","author":"Besseling","year":"2021","journal-title":"Am J Physiol Renal Physiol"},{"key":"2025010614204067500_bib28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/01.HYP.24.1.37","article-title":"Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis","volume":"24","author":"Danser","year":"1994","journal-title":"Hypertension"},{"key":"2025010614204067500_bib29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2025010614204067500_bib30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s40261-015-0279-5","article-title":"An open-label investigation into drug-drug interactions between multiple doses of daclatasvir and single-dose cyclosporine or tacrolimus in healthy subjects","volume":"35","author":"Bifano","year":"2015","journal-title":"Clin Drug Investig"},{"key":"2025010614204067500_bib31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit"},{"key":"2025010614204067500_bib32","first-page":"334","article-title":"Nephrotoxicity of FK-506 in the rat. Studies on glomerular and tubular function, and on the relationship between efficacy and toxicity","volume":"10","author":"Nielsen","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"2025010614204067500_bib33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/toxsci\/kfr217","article-title":"Genomic-derived markers for early detection of calcineurin inhibitor immunosuppressant-mediated nephrotoxicity","volume":"124","author":"Cui","year":"2011","journal-title":"Toxicol Sci"},{"key":"2025010614204067500_bib34","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1681\/ASN.2014111067","article-title":"Deep sequencing in microdissected renal tubules identifies nephron segment-specific transcriptomes","volume":"26","author":"Lee","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2025010614204067500_bib35","doi-asserted-by":"publisher","first-page":"F825","DOI":"10.1152\/ajprenal.00216.2019","article-title":"Mg2+ restriction downregulates NCC through NEDD4-2 and prevents its activation by hypokalemia","volume":"317","author":"Ferdaus","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"2025010614204067500_bib36","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.kint.2021.06.030","article-title":"Specific disruption of calcineurin-signaling in the distal convoluted tubule impacts the transcriptome and proteome, and causes hypomagnesemia and metabolic acidosis","volume":"100","author":"Banki","year":"2021","journal-title":"Kidney Int"},{"key":"2025010614204067500_bib37","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1681\/ASN.2020010071","article-title":"Quantitative proteomics of all 14 renal tubule segments in rat","volume":"31","author":"Limbutara","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2025010614204067500_bib38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1681\/ASN.2008030327","article-title":"EGF increases TRPM6 activity and surface expression","volume":"20","author":"Thebault","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2025010614204067500_bib39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00210-007-0212-4","article-title":"Down-regulation of TRPM6-mediated magnesium influx by cyclosporin A","volume":"377","author":"Ikari","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2025010614204067500_bib40","doi-asserted-by":"publisher","first-page":"8222","DOI":"10.1073\/pnas.82.23.8222","article-title":"Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats","volume":"82","author":"Moss","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025010614204067500_bib41","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/ki.2009.418","article-title":"Inhibition of calcineurin phosphatase promotes exocytosis of renin from juxtaglomerular cells","volume":"77","author":"Madsen","year":"2010","journal-title":"Kidney Int"},{"key":"2025010614204067500_bib42","doi-asserted-by":"publisher","first-page":"e13612","DOI":"10.1111\/apha.13612","article-title":"Angiotensin II receptor blockade alleviates calcineurin inhibitor nephrotoxicity by restoring cyclooxygenase 2 expression in kidney cortex","volume":"232","author":"Hu","year":"2021","journal-title":"Acta Physiol (Oxford)"},{"key":"2025010614204067500_bib43","first-page":"H1596","article-title":"Effect of cyclosporin on blood pressure and renin-aldosterone axis in rats","volume":"253","author":"Lustig","year":"1987","journal-title":"Am J Physiol"},{"key":"2025010614204067500_bib44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/jb\/mvq037","article-title":"Calcineurin mediates the angiotensin II-induced aldosterone synthesis in the adrenal glands by up-regulation of transcription of the CYP11B2 gene","volume":"148","author":"Yamashiro","year":"2010","journal-title":"J Biochem"},{"key":"2025010614204067500_bib45","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.bbrc.2020.11.020","article-title":"The establishment of a novel high-throughput screening system using RNA-guided genome editing to identify chemicals that suppress aldosterone synthase expression","volume":"534","author":"Ito","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"2025010614204067500_bib46","doi-asserted-by":"publisher","first-page":"e157027","DOI":"10.1172\/jci.insight.157027","article-title":"Calcineurin regulates aldosterone production via dephosphorylation of NFATc4","volume":"8","author":"Berber","year":"2023","journal-title":"JCI Insight"},{"key":"2025010614204067500_bib47","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1042\/cs0990285","article-title":"The hypomagnesaemic action of FK506: urinary excretion of magnesium and calcium and the role of parathyroid hormone","volume":"99","author":"Lote","year":"2000","journal-title":"Clin Sci (Lond)"},{"key":"2025010614204067500_bib48","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1097\/01.ASN.0000031702.86799.B9","article-title":"Cyclosporine A suppresses cyclooxygenase-2 expression in the rat kidney","volume":"13","author":"Hocherl","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2025010614204067500_bib49","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1681\/ASN.V11122387","article-title":"Cyclooxygenase-2 in the kidney","volume":"11","author":"Harris","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"2025010614204067500_bib50","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1681\/ASN.2006060664","article-title":"Downregulation of renal sodium transporters and tonicity-responsive enhancer binding protein by long-term treatment with cyclosporin A","volume":"18","author":"Lim","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2025010614204067500_bib51","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1681\/ASN.2017030295","article-title":"Sexual dimorphic pattern of renal transporters and electrolyte homeostasis","volume":"28","author":"Veiras","year":"2017","journal-title":"J Am Soc Nephrol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfae119\/58194726\/gfae119.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/40\/1\/151\/58194726\/gfae119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/40\/1\/151\/58194726\/gfae119.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T09:20:57Z","timestamp":1736155257000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/40\/1\/151\/7680009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,22]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,5,22]]},"published-print":{"date-parts":[[2024,12,20]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfae119","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,5,22]]}}}